U
MSLI

UBS’s Merus Labs International Inc. MSLI Stock Holding History

UBS’s Portfolio MSLI Stock Details MSLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-2,681
Closed -$4K – 11106
2014
Q1 		$4K Buy
2,681
+1,652
+161% +$2.36K ﹤0.01% 9752
2013
Q4 		$1K Buy
+1,029
New +$1.37K ﹤0.01% 10250
2013
Q3 		– Sell
-2,721
Closed -$2K – 10946
2013
Q2 		$2K Buy
+2,721
New +$1.87K ﹤0.01% 9897

Other funds holding MSLI

CIBC Asset Management
CIBC Asset Management Toronto, Ontario, Canada $40.9B AUM 35.96% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IGIM
I.G. Investment Management Winnipeg, Manitoba, Canada $19.5B AUM 15.95% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
PIC
PCJ Investment Counsel Toronto, Ontario, Canada $352M AUM 68.32% 1-Year Est. Return

UBS's MSLI Position: Q2 2014 in Review

UBS sold out of Merus Labs International Inc. (MSLI) in Q2 2014, closing a stake of 2,681 shares — an estimated $4K sold.

UBS first reported a position in MSLI in Q2 2013 and held it in 3 quarters. The position peaked at $4K in Q1 2014. 19 funds tracked by Wall St. Rank hold MSLI as of Q2 2014.

  • UBS reported no remaining Merus Labs International Inc. position as of Q2 2014 after selling out during the quarter.
  • UBS sold 2,681 Merus Labs International Inc. shares in Q2 2014, an estimated $4K.
  • UBS first reported a position in Merus Labs International Inc. in Q2 2013 and held it in 3 quarters.
  • UBS's Merus Labs International Inc. position peaked at $4K in Q1 2014.
  • 19 funds tracked by Wall St. Rank held Merus Labs International Inc. as of Q2 2014.

Based on UBS's 13F filing for Q2 2014, filed 14 Aug 2014.